Management tracks: Flatiron picks Unum’s Vasconcelles to succeed Abernethy; plus Quell, Lytix and more
Flatiron Health Inc. hired Michael Vasconcelles as CMO. Vasconcelles, who was CMO of Unum Therapeutics Inc. (NASDAQ:UMRX), succeeds Amy Abernethy, who left to join FDA as principal deputy commissioner early this year. The Roche (SIX:ROG; OTCQX:RHHBY) unit provides curated real-world data to biopharma companies.
At Unum, Vasconcelles will be succeeded by Jessica Sachs, effective July 15. She was VP of clinical sciences at the T cell therapy company. Unum also hired Matthew Osborne as CFO and Mert Aktar as head of business and corporate development. Osborne was VP of corporate affairs, communications and investor relations at Voyager Therapeutics Inc. (NASDAQ:VYGR); Aktar was global head of hematology and immunology business development at Shire plc...